Kerry lied . . . um, I mean misspoke on this one. Fraudulent drugs are already a significant problem — American bottles and American brands notwithstanding. Like it or not, allowing drug reimportation from Canada increases the traceability problem, and will make ensuring drug safety more difficult. Advanced tracking and labeling systems might address this problem, but they’re not in place yet.
Share this story

About the Author
Jonathan H. Adler is a professor at William & Mary Law School.
Advertisement
Advertisement





Comments